HYBRID PEPTIDES: A NOVEL THERAPEUTIC FRONTIER

Chimera molecules represent a increasingly evolving field in medicinal exploration, presenting a novel strategy to target previously challenging illnesses. Such engineered structures combine various peptide segments, permitting for optimized affinity to diverse targets and possibly circumventing